☆ 4.5 Review

Ketamine for suicidality: An umbrella review

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2022)

Related references

Note: Only part of the references are listed.

Review Pharmacology & Pharmacy

Harm related to recreational ketamine use and its relevance for the clinical use of ketamine. A systematic review and comparison study

Jan Van Amsterdam et al.

Summary: Heavy recreational ketamine use can lead to ketamine dependence and other serious adverse events, which disappear with reduced ketamine use. In contrast, patients treated with ketamine in a clinical context mostly experience mild and reversible SAEs, and ketamine dependency is not reported in these patients.

EXPERT OPINION ON DRUG SAFETY (2022)

Add to Collection

Review Psychology, Developmental

A systematic review of therapeutic ketamine use in children and adolescents with treatment-resistant mood disorders

Susan Kim et al.

Summary: Suicide is the second leading cause of death among individuals aged 10-24 in the United States, and ketamine has been shown to be effective in reducing depressive symptoms in adults. However, studies on ketamine use in youth are limited. Ketamine generally improves depressive symptoms, reduces acute suicidality, and mood lability in youth, although some individuals still show resistance to its treatment. Further longitudinal studies are needed to investigate ketamine's long-term safety, efficacy, and abuse potential in youth.

EUROPEAN CHILD & ADOLESCENT PSYCHIATRY (2021)

Add to Collection

Review Clinical Neurology

Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis

Anees Bahji et al.

Summary: The study showed that intravenous racemic ketamine was more effective and better tolerated than intranasal esketamine for the treatment of unipolar and bipolar major depression.

JOURNAL OF AFFECTIVE DISORDERS (2021)

Add to Collection

Review Emergency Medicine

Ketamine for acute suicidality in the emergency department: A systematic review

Lindsay Maguire et al.

Summary: Studies have shown that ketamine may help alleviate treatment-resistant depression and suicidal ideation, and its use in the emergency department may be a promising and safe intervention.

AMERICAN JOURNAL OF EMERGENCY MEDICINE (2021)

Add to Collection

Review Psychiatry

Improving Suicide Prevention Through Evidence-Based Strategies: A Systematic Review

J. John Mann et al.

Summary: The study found that training primary care physicians in depression recognition and treatment, educating youths on depression and suicidal behavior, and actively following up with patients can effectively prevent suicidal behavior. Other methods such as antidepressants, cognitive-behavioral therapy also show effectiveness in reducing suicidal behavior.

AMERICAN JOURNAL OF PSYCHIATRY (2021)

Add to Collection

Review Psychiatry

The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis

Jiaqi Xiong et al.

Summary: The study aimed to evaluate the acute anti-suicidal ideation effects of single-dose ketamine in different formulations and routes of administration by pooling the results from randomized controlled trials. The findings suggest that intravenous ketamine and intranasal esketamine are associated with robust reductions in suicidal thoughts at 2-h, 4-h, and 24-h post-intervention. Further research on intramuscular, oral, and sublingual ketamine, as well as comparative studies, are needed to evaluate the efficacy of these formulations and routes of administration in reducing suicidal ideation.

JOURNAL OF PSYCHIATRIC RESEARCH (2021)

Add to Collection

Review Public, Environmental & Occupational Health

The rapid anti-suicidal ideation effect of ketamine: A systematic review

Annabella Hochschild et al.

Summary: Suicide rates have been increasing for close to twenty years in many countries, with most attempts and deaths associated with psychiatric illness, typically depression. Subanesthetic ketamine, the only FDA-approved antidepressant that works rapidly, may reduce suicidal ideation in depressed patients, but further research is needed on dosing strategy and long-term efficacy.

PREVENTIVE MEDICINE (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Changes in Suicide Rates — United States, 2018–2019

Deborah M. Stone et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

Add to Collection

Review Psychiatry

The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: A systematic review

Joshua D. Di Vincenzo et al.

Summary: This article summarizes the literature on the effectiveness, safety, and tolerability of ketamine treatment for depression in different age groups. While most studies focus on adult populations, there is less research on adolescents and older adults. Although ketamine shows promising rapid antidepressant effects, the limited quantity and generally low quality of available studies restricts statistical syntheses and conclusions.

JOURNAL OF PSYCHIATRIC RESEARCH (2021)

Add to Collection

Review Psychiatry

Antisuicidal and antidepressant effects of ketamine and esketamine in patients with baseline suicidality: A systematic review

Ashley N. Siegel et al.

Summary: This review evaluated the effects of intranasal esketamine and intravenous ketamine on patients with suicidal ideation. Results indicate that ketamine may rapidly reduce suicidal ideation and depressive symptoms, with potential short-lasting effects. The treatment was deemed relatively safe in the short term, and future clinical trials are encouraged to include this study population.

JOURNAL OF PSYCHIATRIC RESEARCH (2021)

Add to Collection

Review Psychiatry

Immediate and short-term efficacy of suicide-targeted interventions in suicidal individuals: A systematic review

Aiste Lengvenyte et al.

Summary: This study assessed healthcare system-based interventions for individuals with current suicidal ideation or recent suicide attempts. The results showed mixed evidence for the effectiveness of pharmacological and non-pharmacological interventions, with ketamine demonstrating immediate efficacy supported by multiple studies. Further replication studies are needed to validate the effects of other interventions.

WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2021)

Add to Collection

Review Psychology, Clinical

Ketamine Treatment for Depression in Patients With a History of Psychosis or Current Psychotic Symptoms: A Systematic Review

Jolien K. E. Veraart et al.

Summary: A systematic review found that short-term ketamine treatment for depression and negative symptoms in patients with a history of psychosis or current psychotic features can be both safe and effective, with mild and self-limiting side effects. The available literature does not support the assumption that ketamine will exacerbate psychotic symptoms in predisposed patients, but further trials are needed in this patient group due to limited data.

JOURNAL OF CLINICAL PSYCHIATRY (2021)

Add to Collection

Review Psychiatry

The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive Disorder: Recommandations Du Groupe De Travail Du Reseau Canadien Pour Les Traitements De L'humeur Et De L'anxiete (Canmat) Concernant L'utilisation De La Ketamine Racemique Chez Les Adultes Souffrant De Trouble Depressif Majeur

Jennifer Swainson et al.

Summary: Ketamine, particularly when administered intravenously, has rapid antidepressant effects for patients with treatment-resistant depression. Consensus recommendations cover clinical administration, dosages and monitoring for IV ketamine.

CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2021)

Add to Collection

Review Medicine, General & Internal

Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder

Rebecca L. Dean et al.

Summary: The findings suggest that ketamine and esketamine may be more effective than placebo in alleviating acute symptoms of depression. However, there is limited evidence for other glutamate receptor modulators, highlighting the need for more long-term randomized controlled trials to establish comprehensive data on safety and efficacy.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2021)

Add to Collection

Review Psychiatry

Ketamine for suicidal ideation in adults with psychiatric disorders: A systematic review and meta-analysis of treatment trials

Katrina Witt et al.

AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2020)

Add to Collection

Review Clinical Neurology

Adjunctive intranasal esketamine for major depressive disorder: A systematic review of randomized double-blind controlled-placebo studies

Zheng Wei et al.

JOURNAL OF AFFECTIVE DISORDERS (2020)

Add to Collection

Review Medicine, General & Internal

Suicide

Seena Fazel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Review Chemistry, Medicinal

Ketamine Treatment in Depression: A Systematic Review of Clinical Characteristics Predicting Symptom Improvement

Darby J. E. Lowe et al.

CURRENT TOPICS IN MEDICINAL CHEMISTRY (2020)

Add to Collection

Article Pharmacology & Pharmacy

Efficacy of single and repeated administration of ketamine in unipolar and bipolar depression: a meta-analysis of randomized clinical trials

Joanna Kryst et al.

PHARMACOLOGICAL REPORTS (2020)

Add to Collection

Review Clinical Neurology

The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis

Roger S. McIntyre et al.

JOURNAL OF AFFECTIVE DISORDERS (2020)

Add to Collection

Review Psychology

Repurposing Potential of Ketamine: Opportunities and Challenges

C. S. Gautam et al.

INDIAN JOURNAL OF PSYCHOLOGICAL MEDICINE (2020)

Add to Collection

Review Medicine, General & Internal

Treatments for the Prevention and Management of Suicide A Systematic Review

Kristen E. D'Anci et al.

ANNALS OF INTERNAL MEDICINE (2019)

Add to Collection

Article Pharmacology & Pharmacy

THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Ion channels

Stephen P. H. Alexander et al.

BRITISH JOURNAL OF PHARMACOLOGY (2019)

Add to Collection

Article Medicine, General & Internal

Suicide and suicide risk

Gustavo Turecki et al.

NATURE REVIEWS DISEASE PRIMERS (2019)

Add to Collection

Article Psychology, Clinical

Brooding, Inattention, and Impulsivity as Predictors of Adolescent Suicidal Ideation

Katherine L. Sarkisian et al.

JOURNAL OF ABNORMAL CHILD PSYCHOLOGY (2019)

Add to Collection

Article Psychiatry

How Many People Are Exposed to Suicide? Not Six

Julie Cerel et al.

SUICIDE AND LIFE-THREATENING BEHAVIOR (2019)

Add to Collection

Review Psychology, Clinical

Oral Ketamine for Depression: A Systematic Review

Joshua D. Rosenblat et al.

JOURNAL OF CLINICAL PSYCHIATRY (2019)

Add to Collection

Article Psychiatry

Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial

Michael F. Grunebaum et al.

AMERICAN JOURNAL OF PSYCHIATRY (2018)

Add to Collection

Article Psychiatry

The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis

Samuel T. Wilkinson et al.

AMERICAN JOURNAL OF PSYCHIATRY (2018)

Add to Collection

Review Environmental Sciences

Epidemiology of Suicide and the Psychiatric Perspective

Silke Bachmann

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2018)

Add to Collection

Review Biochemistry & Molecular Biology

Eradicating Suicide at Its Roots: Preclinical Bases and Clinical Evidence of the Efficacy of Ketamine in the Treatment of Suicidal Behaviors

Domenico De Berardis et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Add to Collection

Article Behavioral Sciences

Ketamine as a rapid-acting agent for suicidal ideation: A meta-analysis

Francesco Bartoli et al.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2017)

Add to Collection

Article Medicine, General & Internal

AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both

Beverley J. Shea et al.

BMJ-BRITISH MEDICAL JOURNAL (2017)

Add to Collection

Article Medicine, General & Internal

AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both

Beverley J. Shea et al.

BMJ-BRITISH MEDICAL JOURNAL (2017)

Add to Collection

Article Clinical Neurology

Ketamine versus midazolam in bipolar depression with suicidal thoughts: A pilot midazolam-controlled randomized clinical trial

Michael F. Grunebaum et al.

BIPOLAR DISORDERS (2017)

Add to Collection

Review Clinical Neurology

Effects of Low-Dose and Very Low-Dose Ketamine among Patients with Major Depression: a Systematic Review and Meta-Analysis

Ying Xu et al.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2016)

Add to Collection

Article Pharmacology & Pharmacy

A New Perspective on the Anti-Suicide Effects With Ketamine Treatment A Procognitive Effect

Yena Lee et al.

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2016)

Add to Collection

Article Neurosciences

Risks Associated with Misuse of Ketamine as a Rapid-Acting Antidepressant

Weili Zhu et al.

NEUROSCIENCE BULLETIN (2016)

Add to Collection

Review Pharmacology & Pharmacy

Ketamine as a Potential Treatment for Suicidal Ideation: A Systematic Review of the Literature

Lael Reinstatler et al.

DRUGS IN R&D (2015)

Add to Collection

Review Neurosciences

The Role of Ketamine in Treatment-Resistant Depression: A Systematic Review

Gianluca Serafini et al.

CURRENT NEUROPHARMACOLOGY (2014)

Add to Collection

Review Neurosciences

The molecular bases of the suicidal brain

Gustavo Turecki

NATURE REVIEWS NEUROSCIENCE (2014)

Add to Collection

Review Neurosciences

Ketamine administration in depressive disorders: a systematic review and meta-analysis

Guillaume Fond et al.

PSYCHOPHARMACOLOGY (2014)

Add to Collection

Article Pharmacology & Pharmacy

Ketamine as the prototype glutamatergic antidepressant: pharmacodynamic actions, and a systematic review and meta-analysis of efficacy

Caroline Caddy et al.

THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2014)

Add to Collection

Review Neurosciences

Ketamine for Depression: Where Do We Go from Here?

Marije Aan Het Rot et al.

BIOLOGICAL PSYCHIATRY (2012)

Add to Collection

Article Psychiatry

Adolescent suicide

Cendrine Bursztein et al.

CURRENT OPINION IN PSYCHIATRY (2009)

Add to Collection

Article Medicine, General & Internal

Using Second-Generation Antidepressants to Treat Depressive Disorders: A Clinical Practice Guideline from the American College of Physicians

Amir Qaseem et al.

ANNALS OF INTERNAL MEDICINE (2008)

Add to Collection

© Peeref 2019-2024. All rights reserved.